recomBead Borrelia
against Borrelia burgdorferi sensu lato in human serum, plasma or CSF
Mikrogen recomBead Borrelia tests are quantitative immunoassays, with recombinantly produced antigens, for the detection of human antibodies against single, diagnostically relevant Borrelia antigens. They allow a flexible combination of the advantages of ELISA and confirmatory testing on one plate. Simultaneous, separate detection of individual antigen-specific antibodies make classification into early and late phase of Borrelia infection possible.
Products
Advantages
- Use of recombinant Borrelia antigens:
Antigen | Description | Origin |
| p100 | Uncharacterized borrelia-specific antigen | B. afzelii |
| VIsE | Vmp (variable major protein) like sequence Expressed, surface lipoprotein | Fusion protein, representing the immunodominant VIsE epitopes of different genospecies. |
| p58 | Oligopeptide permease | B.garinii |
| p39 | Borrelial membrane protein A (BmpA) | B.afzelii |
| OspA | Outer surface protein, Surface protein A | B.afzelii |
| OspC | Outer surface protein, Surface protein C | B.burgdorferi sensu stricto, B.afzelii, B.garinii |
| p18 | Decorin binding protein A (=DbpA), also called Osp17, Surface protein | B.burgdorferi sensu stricto, B.afzelii, B.garinii, B.spielmanii, B.bavariensis |
- Recombinant antigens - minimal cross-reactivity
- Optimal setting for typing of Borrelia bacteria
- Possibility of quantitative determination of VlsE exists (research use only)
- Serum and CSF diagnostics with determination of the borrelia-specific antibody index (AI)
- Small sample volume (10 μl) is sufficient
- Ideally suited for high sample throughput
- Fully automated processing, software-based evaluation (recomQuant) and connection to the laboratory information system possible
Safe and reliable
Validity check by integrated controls (incubation, conjugate and negative control)
Flexible and compatible
Combination of all microgene recomBead immunoassays possible on one plate - uniform processing and interchangeable reagents
High Standard
CE marking: The recomBead Borrelia tests meet the high requirements of the EC Directive 98/79/EC for in vitro diagnostic medical devices